XML 12 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Net Loss and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
OPERATING EXPENSES        
Research and development $ 19,660 $ 8,731 $ 46,665 $ 23,228
General and administrative 4,699 2,684 12,581 5,924
Total operating expenses 24,359 11,415 59,246 29,152
Loss from operations (24,359) (11,415) (59,246) (29,152)
OTHER INCOME/(EXPENSES)        
Interest and other income/(expenses) 437 (11) 1,354 (62)
NET LOSS (23,922) (11,426) (57,892) (29,214)
Other comprehensive income        
Foreign currency translation 134 39 124 121
COMPREHENSIVE LOSS $ (23,788) $ (11,387) $ (57,768) $ (29,093)
Net loss per share attributable to common stockholders, basic and diluted $ (0.70) $ (0.42) $ (1.69) $ (1.08)
Weighted average common shares outstanding, basic and diluted 34,371,927 27,330,579 34,253,739 26,945,432